Company Encyclopedia
View More
name
VanEck Pharmaceutical ETF
PPH.US
News
View More

Berenberg Bank Keeps Their Buy Rating on Novo Nordisk (0QIU)

Berenberg Bank's Kerry Holford maintains a Buy rating on Novo Nordisk with a DKK400.00 price target. Holford, a 4-star analyst, has an average return of 11.0% and a 59.09% success rate. Deutsche Bank also issued a Buy rating, while UBS maintained a Hold rating on Novo Nordisk.

Tip Ranks·
US
NVO
+0.88%
Tip Ranks·
US
NVO
+0.88%

With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026

Netflix completed a 10-for-1 stock split, making shares more accessible at around $100 each. This move could increase Netflix's chances of joining the Dow Jones Industrial Average. Meta Platforms, ASML, and Eli Lilly are predicted to issue stock splits in 2026, making them attractive growth stocks to buy in December. Meta could replace Verizon in the Dow, ASML is poised for technological advancements in AI chips, and Eli Lilly's success is driven by its GLP-1 medications.

Motley Fool·
US
NFLX
-0.71%
US
ASML
-2.70%
US
META
+3.43%
Motley Fool·
US
NFLX
-0.71%
US
ASML
-2.70%
US
META
+3.43%

Pfizer, GSK, Shionogi sponsor London run of AMR musical

Pfizer, GSK, and Shionogi are sponsoring the London run of the musical "Lifeline" to raise awareness about antimicrobial resistance (AMR). The musical, which tells the story of antibiotic discovery and modern AMR challenges, will play at Southwark Playhouse Elephant from March to May next year. The initiative aims to highlight the growing threat of AMR and the importance of protecting antibiotics. The production also seeks healthcare professionals to join the chorus, emphasizing the collaboration between science and the arts.

Fiercepharma·
US
SGIOY
+2.02%
US
GSK
-0.82%
Fiercepharma·
US
SGIOY
+2.02%
US
GSK
-0.82%

Key facts: GSK Buyback Reaches 237M Shares; CDC Talks Impact Vaccines

On December 4, 2025, GSK plc bought 11,764,733 shares in its buyback program, raising total treasury shares to 237,229,577, which is 5.82% of voting rights.1GSK, with Merck, makes hepatitis B vaccines. Recent CDC ACIP talks on vaccination schedules could impact GSK's vaccine supply and distribution.2

TradingView·
UK
GSK
0.00%
US
GSK
-0.82%
TradingView·
UK
GSK
0.00%
US
GSK
-0.82%

Health Care Down Sharply on Rotation to Rate-Sensitive Sectors -- Health Care Roundup

Health-care stocks fell sharply as traders shifted to rate-sensitive sectors. Halozyme secured a preliminary injunction against Merck & Co. in a patent dispute over Keytruda in Germany. The Trump administration's biomedical innovation goals face challenges within the FDA, amid infighting and staff turnover influenced by Robert F. Kennedy Jr.'s policy changes.

marketscreener·
US
MRK
-1.35%
US
HALO
-2.64%
marketscreener·
US
MRK
-1.35%
US
HALO
-2.64%
© 2025 Longbridge｜Disclaimer